CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. (Q44605144)
Jump to navigation
Jump to search
scientific article published in September 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. |
scientific article published in September 2003 |
Statements
CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models (English)
Bruce Ruggeri
Jasbir Singh
Diane Gingrich
Thelma Angeles
Mark Albom
Shi Yang
Hong Chang
Candy Robinson
Kathryn Hunter
Pawel Dobrzanski
Susan Jones-Bolin
Sonya Pritchard
Lisa Aimone
Andres Klein-Szanto
Jean-Marc Herbert
Francoise Bono
Pierre Casellas
Bernard Bourie
Roberto Pili
John Isaacs
Mark Ator
Robert Hudkins
Jeffrey Vaught
John Mallamo
1 September 2003